Jun. 18 at 11:18 PM
$MDXG Unless the rules have changed,CMS generally publishes their proposed rule for the next calendar year’s reimbursement,including proposed payment rates and methodology changes.This is when you’ll first see any proposed changes to skin substitute reimbursement. There is then a public commenting period through September. Late October or early November, CMS publishes the final rule, which may modify the proposal in response to comments. The new payment schedule becomes effective January first if CMS elects to reconsider reimbursement in July.
If pressure from the past lobby group is sustained, I think there is a good chance that
$127.14 sq cm might be altered. If so, MImedx stands alone with the greatest number of statistically successful studies. In addition,I suspect all of the product that has flooded the market at ten cents on the dollar will have disappeared.Given this algorithm,this investor will hold pat and look to July for some encouraging news.
Hope springs eternal!!
